A Study of LY3471851 in Participants With Psoriasis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
The main purpose of this study is to learn more about the safety of LY3471851 when given by injection just under the skin to participants with psoriasis. The study will last up to 48 weeks and may include up to 23 visits to the study center.
Epistemonikos ID: e49816b1c1fa69bbb80161a9f1fbb479416a007e
First added on: May 22, 2024